Sales veteran to lead next phase of growth for carrier-grade open, disaggregated networking
Santa Clara, CA – December 15, 2025 – IP Infusion, a global leader in open networking software solutions, announced today that Tom Savoie has been appointed Chief Executive Officer. Savoie has held senior leadership roles at IP Infusion, including Chief Sales Officer, and brings nearly three decades of experience across telecom operators, network equipment manufacturers, and networking software companies.
Savoie has worked on both the operator and vendor sides of the market, helping customers transition from proprietary systems to open, virtualized, and disaggregated networks. He joined IP Infusion in an entry-level contributor sales position and, over the past 16 years, has been instrumental in most of the company's largest sales. His prior roles include leadership positions at Nortel and Wind River Systems/Intel, where he focused on white box platforms, network operating systems, and software-defined networking and NFV solutions.
"From my vantage point, IP Infusion is where operators around the world come when they are ready to take disaggregation from pilot to production," said Tom Savoie, CEO of IP Infusion. "That work is only becoming more important as our customers scale for 5G, AI workloads, and cloud connectivity. I look forward to supporting our company's important mission to give operators a carrier-grade alternative to legacy networking stacks so they can choose their hardware and reduce total cost of ownership without sacrificing performance or reliability."
"Tom combines deep technical understanding with frontline commercial experience in open networking," said Kiyo Oishi, President and CEO of ACCESS CO., LTD., the parent company of IP Infusion. "ACCESS sees IP Infusion as a strategic growth engine in our network business. Under Tom's leadership, we expect the company to expand its global footprint and accelerate innovation in disaggregated network operating systems."
With more than 600 customers and tens of thousands of carrier deployments, IP Infusion's OcNOS® network operating system powers open, disaggregated access, aggregation, transport, and data center networks on white box hardware for carriers, network equipment manufacturers, and enterprise data centers worldwide.
Über IP Infusion
IP Infusion develops open network software solutions for carriers, service providers, and data centers. With hundreds of customers and thousands of deployments, IP Infusion leads the market in Network Operating Systems. Its flagship platform, OcNOS®, empowers network operators to disaggregate their networks, streamline operations, and reduce total cost of ownership (TCO). Headquartered in Santa Clara, Calif., IP Infusion is a wholly owned subsidiary of ACCESS CO., LTD. For more information, visit www.ipinfusion.com/.
Media Contact:
Katherine Verducci, 1903 PR
kverducci@1903pr.com
408.429.5779
Über IP Infusion
IP Infusion ist ein führender Anbieter von Open-Networking-Software und liefert OcNOS, ein Carrier-Grade-Netzwerkbetriebssystem für Service Provider, Rechenzentren und AI-Fabric-Netze. Mit Netzwerkerfahrung seit 1999 und 600+ Betreibern weltweit ermöglicht IP Infusion offene, herstellerübergreifende, kosteneffiziente und flexible Netzwerkinfrastruktur auf validierter offener Hardware von Partnern wie Edgecore Networks, UfiSpace und Celestica. IP Infusion ist eine hundertprozentige Tochtergesellschaft der ACCESS CO., LTD. (Tokyo Stock Exchange: 4813).
Pressekontakt
For press inquiries, analyst briefings, or media materials, please unser Team kontaktieren or email pr@ipinfusion.com.
Zukunftsgerichtete Aussagen
Diese Mitteilung kann zukunftsgerichtete Aussagen zu Produkten, Technologien und Plänen von IP Infusion enthalten. Zukunftsgerichtete Aussagen beruhen auf den zum Veröffentlichungsdatum verfügbaren Informationen und sind mit Risiken und Unsicherheiten verbunden. Die tatsächlichen Ergebnisse können abweichen. Produktpläne, Funktionen, Release-Termine und Verfügbarkeit können sich ohne Vorankündigung ändern und stellen keine Zusage, kein Versprechen und keine rechtliche Verpflichtung dar. IP Infusion übernimmt keine Verpflichtung, zukunftsgerichtete Aussagen zu aktualisieren.